Volitionrx (VNRX) Share-based Compensation (2011 - 2025)
Volitionrx (VNRX) reported Share-based Compensation of -$132875.0 for Q4 2025, down 140.79% on a YoY basis from $325738.0 in Q4 2024, and down 116.36% quarter-over-quarter from $812045.0 in Q2 2025.
Volitionrx (VNRX) Share-based Compensation (2011 - 2025) Analysis & Trends
Volitionrx has reported Share-based Compensation for 15 years, with the latest figure at -$132875.0 in Q4 2025.
- For the quarter ending Q4 2025, Share-based Compensation fell 140.79% year-over-year to -$132875.0; the trailing twelve-month figure through Dec 2025 stood at $1.5 million (up 14.8% YoY), and the FY2025 full-year result was $1.7 million, up 37.14% from the prior year.
- Share-based Compensation for Q4 2025 stood at -$132875.0, down from $812045.0 in the prior quarter.
- The five-year high for Share-based Compensation was $915031.0 in Q1 2022, with the low at -$132875.0 in Q4 2025.
- Historically, Share-based Compensation has averaged $512705.1 across 5 years, with a median of $537980.0 in 2023.
- The largest YoY upside for Share-based Compensation was 290.32% in 2025 against a maximum downside of 140.79% in 2025.
- Volitionrx's Share-based Compensation stood at $276729.0 in 2021, then soared by 155.21% to $706249.0 in 2022, then tumbled by 34.06% to $465734.0 in 2023, then sank by 30.06% to $325738.0 in 2024, then sank by 140.79% to -$132875.0 in 2025.
- The last three Share-based Compensation figures came in at -$132875.0 (Q4 2025), $812045.0 (Q2 2025), and $451374.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Volitionrx | 53.00 Mn | 50.54 Mn | -1.01 Mn | -132,875.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -132,875.00 |
| Dec 31, 2025 | -132,875.00 |
| Jun 30, 2025 | 812,045.00 |
| Jun 30, 2025 | 812,045.00 |
| Mar 31, 2025 | 451,374.00 |
| Mar 31, 2025 | 451,374.00 |
| Dec 31, 2024 | 325,738.00 |
| Dec 31, 2024 | 325,738.00 |
| Sep 30, 2024 | 323,539.00 |
| Sep 30, 2024 | 323,539.00 |
| Jun 30, 2024 | 208,046.00 |
| Jun 30, 2024 | 208,046.00 |
| Mar 31, 2024 | 411,220.00 |
| Mar 31, 2024 | 411,220.00 |
| Dec 31, 2023 | 465,734.00 |
| Dec 31, 2023 | 465,734.00 |
| Sep 30, 2023 | 537,980.00 |
| Sep 30, 2023 | 537,980.00 |
| Jun 30, 2023 | 592,174.00 |
| Jun 30, 2023 | 592,174.00 |